Marseille-Kliniken AG

EANS-Adhoc: - New bond of Marseille-Kliniken AG fully placed - Introduction into Open Market of the Frankfurt Stock Exchange is expected for 30 November 2011


--------------------------------------------------------------------------------
  ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro
  adhoc with the aim of a Europe-wide distribution. The issuer is solely
  responsible for the content of this announcement.
--------------------------------------------------------------------------------
29.11.2011

Berlin, 29 November 2011. - Marseille-Kliniken AG (Prime Standard, ISIN DE
0007783003, MKA) announces the complete placement of partial bearer bonds with a
total nominal amount of EUR 15 million. The partial bonds (ISIN DE000A1MASB1)
are expected to be introduced to trading at the Open Market of the Frankfurt
Stock Exchange on 30 November 2011. Duration will be two years with a coupon of
9.5 per cent in the first and 12.5 per cent in the second year.

The offer was executed by way of a private placement to institutional investors
in Germany and Europe.

No offer: This release is neither an offer nor a solicitation for an offer to
purchase securities. The securities of Marseille-Kliniken AG described here are
not offered for sale in the United States and are not registered in accordance
with the U.S. Securities Act.

End, ad hoc release


Further inquiry note:
Christian Hillermann
Hillermann Consulting
Investor Relations for Marseille-Kliniken AG
Poststraße 14/16
20354 Hamburg
Germany
Tel.: +49-(0)40 / 320 279-10
Fax: +49-(0)40 / 320 279-114
www.marseille-kliniken.com

end of announcement                               euro adhoc 
--------------------------------------------------------------------------------


issuer:      Marseille-Kliniken AG
             Alte Jakobstraße 79/80
             D-10179 Berlin
phone:       +49 (0)30 246 32-400
FAX:         +49 (0)30 246 32-401
mail:     info@marseille-kliniken.de
WWW:      http://www.marseille-kliniken.de
sector:      Pharmaceuticals
ISIN:        DE0007783003
indexes:     CDAX, Classic All Share, Prime All Share
stockmarkets: regulated dealing/prime standard: Frankfurt, free trade: Berlin,
             Stuttgart, Düsseldorf, regulated dealing: Hamburg 
language:   English
 

 

 



Das könnte Sie auch interessieren: